相关实验视频
Updated: Jun 10, 2025
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.5K
基斯顿修饰酶和胃癌:基于孟德尔随机化的潜在生物标志物和治疗点的搜索
Wenbo Liu1, Zhiyuan Wang1, Zhiran Yang1
1The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China.
Heliyon
|October 15, 2024
概括
血组织蛋白修饰酶可能因果关系地影响胃癌风险. 像ASH2L,SETMAR和KAT6A这样的特定酶显示出作为这种恶性瘤的新生物标志物和治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 胃癌存在重大挑战,原因是治疗结果差,治疗途径有限.
- 研究等离子体中基因组修饰酶为新的治疗点和生物标志物提供了潜力.
研究的目的:
- 通过使用孟德尔随机化 (MR) 探索血组素修饰酶与胃癌风险之间的因果关系.
- 确定潜在的新生物标志物和治疗点,用于胃癌管理.
主要方法:
- 孟德尔随机化 (MR) 分析利用全基因组关联研究数据对血组质素修饰酶和胃癌.
- 采用逆方差加权 (IVW) 方法作为主要的MR分析技术.
- 进行了敏感性分析和生物信息学分析,以获得可靠性和功能洞察力.
主要成果:
- 前进MR显示ASH2L与胃癌风险之间存在正相关性,而SETMAR则呈负相关性.
- 反向MR显示胃癌发生率和KAT6A表达之间存在负相关性.
- 生物信息学分析证实了ASH2L,SETMAR和KAT6A在包括胃癌在内的各种瘤中的差异表达和预后意义.
结论:
- 血中基因组修饰酶,特别是ASH2L,SETMAR和KAT6A,显示出与胃癌的潜在因果关系.
- 这些酶可能作为胃癌的有价值的生物标志物和治疗点,需要进一步研究.
相关概念视频
02:30Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K